hepatology
59 projects
H2020Individual fellowship2017–2019United Kingdom
CNS-Insuin-Res · How insulin resistance in the dorsal vagal complex affects glucose metabolism and feeding behaviour
H2020Individual fellowship2017–2021United Kingdom
OPN-Can · Investigating the role of OPN-CD44 in mechanosensitive tumour invasion using biomimetic models
2 partners · 2 countries
H2020Staff exchange2017–2022Portugal
mtFOIE GRAS · mitoFOIE GRAS: Non-invasive Profiling of Mitochondrial Function in Non-Alcoholic Fatty Liver Disease
13 partners · 7 countries
H2020Staff exchange2017–2022Portugal
LysoMod · Genetic and Small Molecule Modifiers of Lysosomal Function
14 partners · 9 countries
H2020Doctoral network2017–2021Portugal
Foie Gras · Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease
14 partners · 8 countries
H2020Individual fellowship2017–2020Sweden
TGDNL · Mechanisms of cellular fatty acid homeostasis
2 partners · 2 countries
H2020Individual fellowship2016–2018United Kingdom
EXNADMINA · EXercise as a regulator of hepatic NAD metabolism and MItochondrial function in Non-Alcoholic fatty liver disease
H2020Individual fellowship2016–2018Germany
GCG-T3 Dyslipidemia · Validation and Molecular Characterization of Novel Glucagon-Thyroid Hormone Conjugates for the Efficient Management of Dyslipidemia and Fatty Liver Disease
H2020Individual fellowship2016–2018United Kingdom
EPILIPRO · Elucidating the role of Arid1a in adult liver
H2020Individual fellowship2016–2018United Kingdom
CollBioImag · Development of a cell-based system for high-throughput screening of antifibrotics
H2020Staff exchange2016–2020Greece
MAST4HEALTH · Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH).
15 partners · 8 countries
H2020Individual fellowship2016–2018Denmark
InCisive · creTRAP for in situ Characterization of Fibrosis-Promoting Pathways in Non-alcoholic Fatty Liver Disease
H2020Individual fellowship2016–2018Denmark
EpiLIVER · Characterization and implications of DNA damage response in liver cancer
H2020Individual fellowship2016–2017Belgium
REZONABLE · Regeneration and zonation by ZEB2 of Liver Endothelium
H2020Individual fellowship2015–2017Spain
Liver Bioengineering · Ex vivo Re-vascularization in Porcine Liver Bioengineering - A Critical First Step Towards Effective Transplantation of Bioengineered Livers
H2020Individual fellowship2015–2017Türkiye
EPIRIN · EPIGENETIC REGULATION OF INFLAMMATION IN NAFLD
H2020Individual fellowship2015–2017Denmark
OPEDGP · Omics Phenotyping of Endocrine Disease in the General Population
H2020Individual fellowship2015–2018Spain
TARGEPILIVER · Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs.
FP7Individual fellowship2014–2016Sweden
INTERDRUG · Epigenetic mechanisms underlying inter-individual differences in drug response and hepatic disease
FP7Individual fellowship2014–2016Switzerland
CN-I LIVER THERAPY · POTENTIAL OF INDUCED PLURIPOTENT STEM CELLS FOR THE TREATMENT OF CRIGLER-NAJJAR LIVER DISEASE: A PRECLINICAL SAFETY ASSESSMENT
FP7Individual fellowship2013–2015Italy
Liver IVM · Visualizing liver immunopathology progression during hepatitis B infection by liver Intravital Microscopy (IVM)
FP7Reintegration grant2011–2015Spain
LIPOHCV · HEPATITIS C VIRUS AND HOST LIPOPROTEIN METABOLISM
FP7Staff exchange2011–2015Germany
WILSONINDIA · Novel opportunities for diagnosis and therapy of Wilson’s disease in India
2 partners · 2 countries
FP7Individual fellowship2011–2012United Kingdom